Beacon Investment Advisory Services, Inc. Nektar Therapeutics Transaction History

Beacon Investment Advisory Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$16.91 - $36.27 $133,775 - $286,931	-7,911 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$31.0 - $36.3 $403 - $471	-13 Reduced 0.16%	7,911 $281,000
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $505 - $741	-16 Reduced 0.2%	7,924 $266,000
Q4 2018 Feb 08, 2019	BUY	$30.43 - $56.65 $241,614 - $449,801	7,940 New	7,940 $261,000

142

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.